Home » today » Business » The “new force” of the emerging cabinet has undergone a major shake-up with 14 players included in this club- Business Times

The “new force” of the emerging cabinet has undergone a major shake-up with 14 players included in this club- Business Times

The 14th gear of the “new force” that has emerged has entered the 100-yuan club

The booming high-priced army “the waves behind the Yangtze River push the waves ahead”! As of the 17th, there were 24 stocks with a high price of more than 100 yuan, and a total of 14 “new blood” stocks joined. Yuzhan New Drug (6785), Handa (6620), and Xinyao (6634) 3 biotechnology and medical stocks Rise up and successfully join the “100-Yuan Club”; and the newly registered MediaTek Xiaojinji Dafa (6526) registered in June last year, and it also directly won the throne of “Emerging Stocks King”.

The performance of Taiwan stocks in the Year of the Tiger is “tiger falls in peace”, but the high-priced stocks in the stock market have not lost their luster. A total of 14 members of the “100-yuan club” have been added to the stock market in the year of the golden tiger, including three stocks whose stock prices have risen above 100 yuan, and 11 Files are emerging as “high-priced new forces”.

There has been a big change in the high-priced stock stocks in the emerging market. Although the members of the “former high-priced stock companies in the stock market” such as eCloudvalley, Taiwan Elite, Green World Technology, Caiyu, Laijie, Acer Information, and Vision have “graduated” from the stock market in succession, The emerging high-priced stocks are still rising stars. According to statistics, among the top ten high-priced stocks that have emerged, six of them are new members added in the year of the golden tiger.

Inspired by the repeated COVID-19 epidemic and the theme of drug rush in mainland China, last year seemed to be the “first year of biotechnology” for the emergence of cabinets. Yuzhan New Drug, Handa, and Xinyao’s three golden tigers soared 209.35%, 123.1%, and 18.92% respectively in the past year.

Among them, Yuzhan New Drug, as one of the targets held by the National Development Fund, has won the “Increase King” in 2022. The average price has soared from 44.16 yuan on the closing day of the Year of the Taurus to 136.61 yuan on the 17th, showing its talents , has become the tenth largest high-priced stock in the emerging cabinet.

As for Handa, a research and development company of special generic drugs, the average price also broke through the 100-yuan mark. Compared with the 6.43 billion yuan in the closing day of the year of the Taurus, it is a 1.38-fold increase.

In addition, the newly registered high-priced “new force” is also powerful. In the past few years of Jinhu, there have been Dafa, Juhan, Xinyingcai, Kangpei, Xianguanke, Boxin, Gaofu, Texhong-Xin, Hongshuo System, Runde, and Chen The average price of Yao-Xin 11 files has exceeded 100 yuan.

MediaTek’s “Golden Rooster” Dafa entered the emerging market last year at 650 yuan per share. Not only did the highest price on that day soar to 800 yuan, but the average price also hit 721.6 yuan, an increase of 11.02%. The subsequent stock price weakened, and the average price on the 17th was still 545.89 yuan. At the end of last year, it submitted an application for listing. It is expected to become the most important recruit in the market in the Year of the Golden Rabbit.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.